BOK Financial enters the final stretch before its July 20 earnings with a notable analyst downgrade landing at the top of the week, even as the stock has posted its strongest monthly gain in some time.
Raymond James downgraded BOKF to Market Perform from Outperform on July 1 — a meaningful step back from one of the stock's more constructive voices heading into the print. The timing is pointed: the stock has rallied 8.5% over the past month to $138.88, and the Street's mean price target now sits at $145.22, leaving just 4.6% implied upside from current levels. That gap has effectively collapsed, which explains why Citigroup, while lifting its target a notch to $141 on June 25, stayed at Neutral. Benchmark also initiated coverage at Hold the same day. The direction of travel from the analyst community has turned firmly sideways — no one is cutting the stock aggressively, but the upgrade cycle that accompanied earlier target raises from RBC, Barclays, and DA Davidson appears to have run its course for now.
The bull case rests on BOKF's low-cost deposit base, its southwest and mountain-west footprint, and a track record of acquisitions that has historically supported long-term asset growth toward the $100 billion milestone. Bears counter with near-term pressure on pre-provision net revenue, ongoing headwinds from loan loss provisioning, and management signaling less appetite for deals — which removes one of the stock's traditional growth levers. On valuation, the P/E has drifted higher to roughly 13.2x over the past month as the rally ran ahead of estimates, while book value sits at 1.26x. Neither multiple screams expensive for a regional bank, but neither screams cheap relative to the quality constraints the ORTEX factor scores highlight: EPS surprise ranks in the 80th percentile and the 90-day EPS momentum is strong at the 81st percentile, yet forward EPS growth momentum has faded to the 24th percentile and the short-score rank is a low 2nd percentile — suggesting most of the near-term bearish positioning has already been unwound.
Short interest is a secondary angle here rather than the main story. BOKF's short interest runs at 3.4% of the free float — up about 4.7% on the week but coming off a base that has barely moved in a month. Borrow conditions remain loose: availability runs at 572%, meaning roughly five and a half shares are available to borrow for every share already short, and well above the 52-week low of 204%. Cost to borrow has eased 15.6% over the week to 0.44%, a subdued level that has barely flickered all year. There is no squeeze setup here, and no sign that shorts are pressing an aggressive directional bet — the positioning looks routine rather than charged.
Options are mildly more cautious than normal. The put/call ratio at 0.65 is modestly above its 20-day average of 0.55, though the z-score of 0.71 is well within one standard deviation — this is hedging ahead of an earnings date rather than anything structural. The PCR spiked closer to 0.79 in the week of June 22-23 before fading back, suggesting some traders took on protection early and have since relaxed. The 52-week range on the PCR runs from 0.17 to 1.46, so current readings are comfortably in the middle of the distribution.
Ownership tells an important structural story. Founder George Kaiser holds 62.5% of shares, leaving a genuinely thin float — a feature that suppresses both short-selling activity and institutional turnover. Stacy Kymes, the President and CEO, sold $2.25 million worth of shares in February following a stock award, a transaction that reads more like routine compensation-plan mechanics than a directional signal. Subsequent insider activity has been minor sales from a subsidiary CEO and a director, all in May at prices in the $132-135 range — below where the stock trades today.
The Q1 print on April 21 saw the stock dip 1.5% on the day and extend losses to 2.3% over the following week. The most recent earnings event in May produced a 1.9% gain on the day but gave back ground over five days. That two-print pattern — modest reaction, brief follow-through in either direction — sets the context for what to watch on July 20: whether the compressed analyst consensus, fading forward EPS momentum, and the Raymond James pullback reflect a genuine re-rating pause, or whether another solid credit-quality quarter is enough to reopen the upgrade cycle.
See the live data behind this article on ORTEX.
Open BOKF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
